The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Intracranial Arteries of Human Fetuses Are More Resistant to Hypercholesterolemia-Induced Fatty Streak Formation Than Extracranial Arteries
Abstract
Background —Atherosclerotic lesions in intracranial arteries occur later and are less extensive than in extracranial arteries. To investigate potential mechanisms responsible for this difference, in particular the atherogenic response to hypercholesterolemia and LDL oxidation, we compared the extent of fatty streak formation and the composition of these very early lesions in intracranial arteries of human fetuses from normocholesterolemic and hypercholesterolemic mothers with those in extracranial arteries. Methods and Results —Lesions were quantified by computer-assisted image analysis of 30 oil red O–stained sections, each from the middle cerebral, basilar, and common carotid arteries and the abdominal aorta of human fetuses (spontaneous abortions and premature newborns who died within 12 hours of birth; both of fetal age 6.2±1.3 months) from 43 hypercholesterolemic mothers and 34 normocholesterolemic mothers. Macrophages, apolipoprotein B, and 2 epitopes of oxidized LDL in lesions were determined immunocytochemically. Activities of superoxide dismutase, catalase, and glutathione peroxidase in the arterial wall were also determined. Lesion numbers and sizes were dramatically greater in the abdominal aorta (area of the largest lesion per section: 66.5±10.9 ×10 3 μm 2 ) and the carotid (11.6±5.3 ×10 3 μm 2 ) than in the basilar and middle cerebral artery (0.4±0.1 and 0.8±0.2 ×10 3 μm 2 , respectively; P <0.0001). Hypercholesterolemia resulted in a significant increase of lesion size in extracranial arteries but only a marginal increase in intracranial arteries. In analogy, hypercholesterolemia induced a much greater increase in the intimal presence of macrophages, apolipoprotein B, and oxidized LDL (oxidation-specific epitopes) in extracranial than in intracranial arteries. Immunocytochemistry did not indicate that lesions of intracranial arteries contain relatively less oxidized LDL than similar-size lesions of extracranial arteries. Activities of Mn–superoxide dismutase but not of Zn–superoxide dismutase, catalase, or glutathione peroxidase were significantly higher in both intracranial arteries. Conclusions —Exposure to hypercholesterolemia during fetal development results in extensive formation of fatty streaks in extracranial but not intracranial arteries. The fact that such a difference in lesion formation occurs in the absence of many other atherogenic risk factors found later in life suggests that differences in the atherogenic response to hypercholesterolemia are an important contributor to the slower onset of the disease in intracranial vessels in adults. Fetal arteries may allow elucidation of the mechanisms responsible, for example, better protection of intracranial arteries against free radical–mediated atherogenic processes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the absence of other atherogenic risk factors, hypercholesterolaemia during foetal development induces an extensive formation of fatty streaks in extracranial arteries but not in intracranial arteries.
“Furthermore, a comparison of intracranial vs. extracranial fatty streak formation of human foetuses from normocholesterolaemic and hypercholesterolaemic mothers shows that, in the absence of other atherogenic risk factors, hypercholesterolaemia during foetal development induces an extensive formation of fatty streaks in extracranial arteries but not in intracranial arteries.19”
From Canonical Wnt pathway and the LDL receptor superfamily in neuronal cholesterol homeostasis and function (2024) · cites this paper as [19]
Citations
Cites
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
Shepherd, J., Cobbe, S. M., Ford, I., Isles, C. G., Lorimer, A. R., Macfarlane, P. W., McKillop, J. H., & Packard, C. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511163332001 · Cited by 7,449
Napoli, C., D'Armiento, F. P., Mancini, F. P., Postiglione, A., Witztum, J. L., Palumbo, G., & Palinski, W. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119813 · Cited by 1,014
Self-citation
Flagged first, then by citations
Research works printed but not linked: 40
- 10.1001/jama.1985.03350380096029 · DOI
- Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383–1389.
- Furberg CD, Pitt B, Byington RP, Park JS, McGovern ME. Reduction in coronary events during treatment with pravastatin: PLAC I and PLAC II Investigators: Pravastatin Limitation of Atherosclerosis in the Coronary Arteries. Am J Cardiol. 1995;76:60C–63C. · DOI
- 10.1161/circ.92.9.2419 · DOI
- 10.1056/NEJM199610033351401 · DOI · Paper page
- 10.1046/j.1365-2796.1997.110123000.x · DOI
- 10.1097/00041433-199508000-00008 · DOI
- 10.1161/circ.27.5.929 · DOI
- McGill HC, Arias-Stella J, Carbonell LM, Correa P, DeVeyra EA, Donoso S, Eggen DA, Galindo L, Guzman MA, Lichtenberger E, Loken C, McGarry PA, McMahan CA, Montenegro MR, Moossy J, Perez-Tamayo R, Restrepo C, Robertson WB, Salas J, Solberg LA, Strong JP, Tejada C, Wainwright J. General findings of the International Atherosclerosis Project. Lab Invest. 1968;18:498–512.
- Wissler RW, Vesselinovitch D. Atherosclerosis in nonhuman primates. Adv Vet Sci Comp Med. 1977;21:351–420.
- 10.1001/jama.1997.03550040069040 · DOI · Paper page
- 10.1161/str.28.5.946 · DOI
- 10.7326/0003-4819-119-2-199307150-00008 · DOI
- 10.1161/atv91.13.9.8364013 · DOI
- 10.1172/JCI115499 · DOI
- 10.1161/circ.91.9.2488 · DOI
- 10.1074/jbc.272.34.20963 · DOI
- 10.1016/0005-2760(72)90018-5 · DOI
- 10.1016/0026-0495(90)90046-F · DOI
- 10.1161/01.ATV.10.3.325 · DOI
- Gown AM, Tsukada T, Ross R. Human atherosclerosis: immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol. 1986;125:191–207.
- 10.1016/0006-291X(76)90747-6 · DOI
- 10.1016/S0076-6879(84)05016-3 · DOI · Paper page
- Marklund SL. Pyrogallol autoxidation. In: Greenwald RA ed. CRC Handbook of Methods for Oxygen Radical Research. Boca Raton Fla: CRC Press Inc; 1985:243–255.
- 10.1016/S0021-9258(19)52451-6 · DOI
- Weber G Biancardi G Cneit L Resi L Salvi M Tanganelli P. Delayed cerebral atherosclerosis involvement in WHHL rabbits. In: Crepaldi G Gotto AM Jr Manzato E Baggio G eds. Atherosclerosis VIII. Heidelberg Germany: Springer Verlag; 1989:125–128.
- 10.1161/circ.85.1.1728483 · DOI
- 10.1161/circ.89.5.8181179 · DOI
- 10.1161/01.ATV.4.4.341 · DOI
- 10.1042/cs0880311 · DOI
- 10.1016/S0022-2275(20)37560-X · DOI
- 10.1083/jcb.34.1.207 · DOI · Paper page
- 10.1227/00006123-199604000-00031 · DOI
- 10.1172/JCI118853 · DOI
- Palinski W, Hörkkö S. Biological consequences of oxidation in atherosclerosis and other pathologies: lipoprotein oxidation in brain arteries. Nutr Metab Cardiovasc Dis. 1997;7:237–247.
- 10.1161/circ.79.3.2917393 · DOI
- 10.1161/str.28.11.2266 · DOI
- 10.1073/pnas.93.19.10417 · DOI
- 10.1038/362801a0 · DOI
- Libby P, Galis ZS. Cytokines regulate genes involved in atherogenesis. Ann N Y Acad Sci. 1995;748:158–168.
Cited by
Sorted by citations
Nitric oxide and pathogenic mechanisms involved in the development of vascular diseases
Napoli, C., & Ignarro, L. J. (2009) · Archives of Pharmacal Research · doi:10.1007/s12272-009-1801-1 · Cited by 281
Role of oxidative stress and AT1 receptors in cerebral vascular dysfunction with aging
Modrick, M. L., Didion, S. P., Sigmund, C. D., & Faraci, F. M. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00300.2009 · Cited by 108
Park, K., Wei, J., Minissian, M., Bairey Merz, C. N., & Pepine, C. J. (2015) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-015-6597-2 · Cited by 40
Borrell-Pages, M., Luquero, A., Vilahur, G., Padró, T., & Badimon, L. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvad159 · Cited by 10
Metadata
- Authors
- Napoli, C., Witztum, J. L., de Nigris, F., Palumbo, G., D’Armiento, F. P., & Palinski, W.
- Affiliations
- From the Department of Clinical and Experimental Medicine (C.N.), the Department of Human Pathology (F.d.N., F.P.D.), and the Department of Molecular and Cellular Biology (G.P.), Federico II University of Naples (Italy), and the Department of Medicine (C.N., J.L.W., W.P.), University of California, San Diego, La Jolla.
- Venue
- Circulation
- Published
- 1999-04-20
- Volume
- 99
- Issue
- 15
- Pages
- 2003-2010
- ISSN
- 0009-7322
- 1524-4539
- Cited by
- 110
- References
- 2
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review